Suppr超能文献

β地中海贫血患者甲状腺激素和铁蛋白水平的评估

Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia.

作者信息

Hussein Sura Zahim

机构信息

Salah Aldeen Health Directorate, Clinical Biochemistry Unit, Tikrit, Iraq.

出版信息

Med Pharm Rep. 2022 Apr;95(2):152-157. doi: 10.15386/mpr-2053. Epub 2022 Apr 28.

Abstract

BACKGROUND AND AIMS

Thalassemia is a condition that affects hemoglobin synthesis and is one of the most common hereditary illnesses in the world. Patients with thalassemia major require several blood transfusions. Multiple blood transfusions cause thyroid dysfunction, which leads to iron excess.

METHODS

From August 2019 to January 2020, serum samples were obtained from 90 persons, 30 of whom were healthy, and 60 (46 male and 44 female) with β-thalassemia major, aged 5-20 years, who visited the thalassemia care center at Salah Aldeen General Hospital in Tikrit city.

RESULTS

Patients had a significant increase (P≤0.01) in T4 and TSH hormones when compared to controls, whereas T3 was also significantly higher (P≤0.05) than in controls. Compared to controls, the level of ferritin had a very significant increase (P≤0.01) in all the study patients with beta-thalassemia, male and female.

CONCLUSIONS

Thyroid disorders are common in β-thalassemia patients who have been transfused multiple times.

摘要

背景与目的

地中海贫血是一种影响血红蛋白合成的疾病,是世界上最常见的遗传性疾病之一。重型地中海贫血患者需要多次输血。多次输血会导致甲状腺功能障碍,进而导致铁过量。

方法

2019年8月至2020年1月,从90人身上采集血清样本,其中30人健康,60人(46名男性和44名女性)为5至20岁的重型β地中海贫血患者,他们前往提克里特市萨拉赫·丁综合医院的地中海贫血护理中心就诊。

结果

与对照组相比,患者的T4和TSH激素显著升高(P≤0.01),而T3也显著高于对照组(P≤0.05)。与对照组相比,所有研究的β地中海贫血患者(无论男女)的铁蛋白水平都有非常显著的升高(P≤0.01)。

结论

多次输血的β地中海贫血患者常见甲状腺疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9617/9176303/56b9db32f4ec/cm-95-152f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验